Gossamer Bio, Inc. ( GOSS) - Key Metrics
GOSS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | $0.05 | -$0.12 | -$0.12 |
| 2026Q1 | $0.07 | -$0.20 | -$0.17 | -$0.17 |
| 2025Q4 | $0.06 | -$0.21 | -$0.21 | -$0.21 |
| 2025Q3 | $0.06 | -$0.21 | -$0.16 | -$0.16 |
| 2025Q2 | $0.05 | -$0.17 | -$0.21 | -$0.21 |
GOSS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.78 |
| 2026Q1 | 0% | -0.41 |
| 2025Q4 | 0% | -3.69 |
| 2025Q3 | 0% | -3.13 |
| 2025Q2 | 0% | -1.81 |
GOSS
Price: $0.14
52 week price:
Earnings Per Share: -0.60 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 916653
Market Capitalization: 68.4 million